Adverum Biotechnologies | 10-Q: Q2 2024 Earnings Report
Adverum Biotechnologies | 8-K: Adverum Biotechnologies Reports Second Quarter 2024 Financial Results and Provides Program and Corporate Highlights
Adverum Biotechnologies | 4: Statement of changes in beneficial ownership of securities-Officer Soparkar Peter
Adverum Biotechnologies | 4: Statement of changes in beneficial ownership of securities-Officer Seyedkazemi Setareh
Adverum Biotechnologies | 4: Statement of changes in beneficial ownership of securities-Officer Rubinstein Linda M
Adverum Biotechnologies | 4: Statement of changes in beneficial ownership of securities-Officer Fischer Laurent
Adverum Biotechnologies | 4: Statement of changes in beneficial ownership of securities-Officer Ozden Rabia Gurses
Adverum Biotechnologies | 4: Statement of changes in beneficial ownership of securities-10% Owner Leonard Braden Michael
Adverum Biotechnologies | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Braden M Leonard(10.6%),BML Investment Partners, L.P.(10.1%)
Adverum Biotechnologies | 3: Initial statement of beneficial ownership of securities-10% Owner Leonard Braden Michael
Adverum Biotechnologies | 4: Statement of changes in beneficial ownership of securities-10% Owner Leonard Braden Michael
Adverum Biotechnologies | 8-K: Current report
Adverum Biotechnologies | S-8: Initial registration statement for securities to be offered to employees pursuant to employee benefit plans
Adverum Biotechnologies | 4: Statement of changes in beneficial ownership of securities-Director Svoronos Dawn
Adverum Biotechnologies | 4: Statement of changes in beneficial ownership of securities-Officer Ozden Rabia Gurses
Adverum Biotechnologies | 4: Statement of changes in beneficial ownership of securities-Director Nicholson, C. David
Adverum Biotechnologies | 4: Statement of changes in beneficial ownership of securities-Director Hong Soo
Adverum Biotechnologies | 4: Statement of changes in beneficial ownership of securities-Director Lupher, Jr. Mark L.
Adverum Biotechnologies | 4: Statement of changes in beneficial ownership of securities-Director Kiss Szilard
Adverum Biotechnologies | 4: Statement of changes in beneficial ownership of securities-Director Machado Patrick
No Data
No Data